Radiology services firm U.S. Diagnostic has signed an agreement with Steel Partners II that allows Steel Partners to purchase up to 45% of U.S. Diagnostic’s voting stock without prior board approval. Steel Partners already owns approximately 15% of
Radiology services firm U.S. Diagnostic has signed an agreement with Steel Partners II that allows Steel Partners to purchase up to 45% of U.S. Diagnostics voting stock without prior board approval. Steel Partners already owns approximately 15% of U.S. Diagnostics stock.
The move comes as West Palm Beach, FL-based U.S. Diagnostic seeks to bolster its business. In the first three quarters of 1999, the company sold its underperforming facilities in Texas (SCAN 3/3/99) and fell from its first place position in the imaging center market to third, according to a report by SMG Marketing Group of Chicago (SCAN 1/19/00).
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.